<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39555074</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Prediction of the risk of mortality in older patients with coronavirus disease 2019 using blood markers and machine learning.</ArticleTitle><Pagination><StartPage>1445618</StartPage><MedlinePgn>1445618</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1445618</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1445618</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">The mortality rate among older people infected with severe acute respiratory syndrome coronavirus 2 is alarmingly high. This study aimed to explore the predictive value of a novel model for assessing the risk of death in this vulnerable cohort.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We enrolled 199 older patients with coronavirus disease 2019 (COVID-19) from Zhejiang Provincial Hospital of Chinese Medicine (Hubin) between 16 December 2022 and 17 January 2023. Additionally, 90 patients from two other centers (Qiantang and Xixi) formed an external independent testing cohort. Univariate and multivariate analyses were used to identify the risk factors for mortality. Least absolute shrinkage and selection operator (LASSO) regression analysis was used to select variables associated with COVID-19 mortality. Nine machine-learning algorithms were used to predict mortality risk in older patients, and their performance was assessed using receiver operating characteristic curves, area under the curve (AUC), calibration curve analysis, and decision curve analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Neutrophil-monocyte ratio, neutrophil-lymphocyte ratio, C- reactive protein, interleukin 6, and D-dimer were considered to be relevant factors associated with the death risk of COVID-19-related death by LASSO regression. The Gaussian naive Bayes model was the best-performing model. In the validation cohort, the model had an AUC of 0.901, whereas in the testing cohort, the model had an AUC of 0.952. The calibration curve showed a good correlation between the actual and predicted probabilities, and the decision curve indicated a strong clinical benefit. Furthermore, the model had an AUC of 0.873 in an external independent testing cohort.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">In this study, a predictive machine-learning model was developed with an online prediction tool designed to assist clinicians in evaluating mortality risk factors and devising targeted and effective treatments for older patients with COVID-19, potentially reducing the mortality rates.</AbstractText><CopyrightInformation>Copyright © 2024 Zhu and Yao.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Linchao</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Medical Laboratory, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yao</LastName><ForeName>Yimin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Medical Laboratory, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C036309">fibrin fragment D</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005338">Fibrin Fibrinogen Degradation Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-41-4</RegistryNumber><NameOfSubstance UI="D002097">C-Reactive Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="Y">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005338" MajorTopicYN="N">Fibrin Fibrinogen Degradation Products</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002097" MajorTopicYN="N">C-Reactive Protein</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012372" MajorTopicYN="N">ROC Curve</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Gaussian naïve Bayes</Keyword><Keyword MajorTopicYN="N">blood markers</Keyword><Keyword MajorTopicYN="N">machine learning</Keyword><Keyword MajorTopicYN="N">mortality</Keyword><Keyword MajorTopicYN="N">older patients</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>6</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39555074</ArticleId><ArticleId IdType="pmc">PMC11563789</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1445618</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>
Worldmeters: COVID-19 Updates: Real-time database and live updates of Covid-19 cases (n.d.). Available online at: http://www.worldometers.info/coronavirus/64. (Accessed February 03, 2024).</Citation></Reference><Reference><Citation>Hu B, Guo H, Zhou P, Shi ZL. Characteristics of SARS-coV-2 and COVID-19. Nat Rev Microbiol. (2021) 19:141–54. doi: 10.1038/s41579-020-00459-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-020-00459-7</ArticleId><ArticleId IdType="pmc">PMC7537588</ArticleId><ArticleId IdType="pubmed">33024307</ArticleId></ArticleIdList></Reference><Reference><Citation>
Centers for Disease Control and Prevention Risk for COVID-19 Infection, Hospitalization, and Death by Age . Available online at: https://www.cdc.gov/coronavirus/2019-ncov/coviDData/investigations-discovery/hospitalization-death-by-age.html (Accessed August 3, 2022).</Citation></Reference><Reference><Citation>Azar A, Ballas ZK. Immune function in older adults, in: UpToDate . Waltham, MA: UpToDate; (Accessed July 29, 2022).</Citation></Reference><Reference><Citation>Gold JAW, Rossen LM, Ahmad FB, Sutton P, Li ZY, Salvatore PP, et al. . Race, ethnicity, and age trends in persons who died from COVID-19 in the United States from May to August 2020. MMWR Morb Mortal Wkly Rep. (2020) 69:1517–21. doi: 10.15585/mmwr.mm6942e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6942e1</ArticleId><ArticleId IdType="pmc">PMC7583501</ArticleId><ArticleId IdType="pubmed">33090984</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafson CE, Kim C, Weyand CM, Goronzy JJ. Effects of immune aging on the vaccine responses. J Allergy Clin Immunol. (2020) 145:1309–21. doi: 10.1016/j.jaci.2020.03.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.03.017</ArticleId><ArticleId IdType="pmc">PMC7198995</ArticleId><ArticleId IdType="pubmed">32386655</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinrichs B, Eickhoff SB. Your evidence? Machine learning algorithms for medical diagnosis and prediction. Hum Brain Mapp. (2020) 41:1435–44. doi: 10.1002/hbm.24886</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hbm.24886</ArticleId><ArticleId IdType="pmc">PMC7268052</ArticleId><ArticleId IdType="pubmed">31804003</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong ZS, Zhou J, Zhang Q. Artificial intelligence for infectious disease big data analytics. Infect Dis Health. (2019) 24:44–8. doi: 10.1016/j.idh.2018.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idh.2018.10.002</ArticleId><ArticleId IdType="pubmed">30541697</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, Zhang D, Wang W, Li XW, Yang B, Song JD, et al. . A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. (2020) 382:727–33. doi: 10.1056/NEJMoa2001017</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Kruip M, van der Meer NJM, Arbous MS, Gommers DAMPJ, Kant KM, et al. . Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. (2020) 191:145–7. doi: 10.1016/j.thromres.2020.04.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.013</ArticleId><ArticleId IdType="pmc">PMC7146714</ArticleId><ArticleId IdType="pubmed">32291094</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. Summary of a report of 72 314 cases from the chinese center for disease control and prevention. JAMA. (2020) 323:1239–42. doi: 10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, He R, Wu R, Wang B, Xu H, Zhang Y, et al. . Mycoplasma pneumonia-associated thrombosis at Beijing Children’s hospital. BMC Infect Dis. (2020) 20:51. doi: 10.1186/s12879-020-4774-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-4774-9</ArticleId><ArticleId IdType="pmc">PMC6966865</ArticleId><ArticleId IdType="pubmed">31948402</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Yan X, Fan Q, Liu H, Liu X, Liu Z, et al. . D-Dimer levels on admission to predict in-hospital mortality in patients with Covid-19. J Thromb Haemost. (2020) 18:1324–9. doi: 10.1111/jth.14859</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.14859</ArticleId><ArticleId IdType="pmc">PMC7264730</ArticleId><ArticleId IdType="pubmed">32306492</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulaei K, Shanbehzadeh M, Mohammadi-Taghiabad Z, Kazemi-Arpanahi H. Comparison machine learning algorithms for predicting COVID-19 mortality. BMC Med Inform Decis Mak. (2022) 22:2. doi: 10.1186/s12911-021-01742-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12911-021-01742-0</ArticleId><ArticleId IdType="pmc">PMC8724649</ArticleId><ArticleId IdType="pubmed">34983496</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, et al. . Factors associated with COVID-19-related death using Open SAFELY. Nature. (2020) 584:430–6. doi: 10.1038/s41586-020-2521-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2521-4</ArticleId><ArticleId IdType="pmc">PMC7611074</ArticleId><ArticleId IdType="pubmed">32640463</ArticleId></ArticleIdList></Reference><Reference><Citation>Kononenko I. Machine learning for medical diagnosis: History, state of the art and perspective. Artif Intell Med. (2001) 23:89–109. doi: 10.1016/S0933-3657(01)00077-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0933-3657(01)00077-X</ArticleId><ArticleId IdType="pubmed">11470218</ArticleId></ArticleIdList></Reference><Reference><Citation>Lian J, Jin X, Hao S, Cai H, Zhang S, Zheng L, et al. . Epidemiological and clinical features in older patients with coronavirus disease 2019 (COVID-19) outside Wuhan. Clin Infect Dis. (2020) 71:740–7. doi: 10.1093/cid/ciaa242</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa242</ArticleId><ArticleId IdType="pmc">PMC7184356</ArticleId><ArticleId IdType="pubmed">32211844</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ. SARS-CoV-2 and COVID-19 in older adults: What is expected regarding the pathogenesis, immune responses, and outcomes? Geroscience. (2020) 42:505–14. doi: 10.1007/s11357-020-00186-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11357-020-00186-0</ArticleId><ArticleId IdType="pmc">PMC7145538</ArticleId><ArticleId IdType="pubmed">32274617</ArticleId></ArticleIdList></Reference><Reference><Citation>McMichael TM, Currie DW, Clark S, Pogosjans S, Kay M, Schwartz NG, et al. . Epidemiology of Covid-19 in a long-term care facility in King County, Washington, USA. N Engl J Med. (2020) 382:2005–11. doi: 10.1056/NEJMoa2005412</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2005412</ArticleId><ArticleId IdType="pmc">PMC7121761</ArticleId><ArticleId IdType="pubmed">32220208</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. (2020) 368:473–4. doi: 10.1126/science.abb8925</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb8925</ArticleId><ArticleId IdType="pubmed">32303591</ArticleId></ArticleIdList></Reference><Reference><Citation>Karki R, Kanneganti TD. Innate immunity, cytokine storm, and inflammatory cell death in Covid-19. J Transl Med. (2022) 20:542. doi: 10.1186/s12967-022-03767-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-022-03767-z</ArticleId><ArticleId IdType="pmc">PMC9682745</ArticleId><ArticleId IdType="pubmed">36419185</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AP, Liu JP, Liu WP, Tao WQ, Li HM. The diagnostic and predictive roles of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. (2020) 84:106504. doi: 10.1016/j.intimp.2020.106504</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.106504</ArticleId><ArticleId IdType="pmc">PMC7152924</ArticleId><ArticleId IdType="pubmed">32304994</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye W, Chen G, Li X, Lan X, Ji C, Hou M, et al. . Dynamic changes in D-dimer levels and neutrophil-lymphocyte count ratios as prognostic biomarkers for COVID-19. Respir Res. (2020) 21:169. doi: 10.1186/s12931-020-01428-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01428-7</ArticleId><ArticleId IdType="pmc">PMC7332531</ArticleId><ArticleId IdType="pubmed">32620118</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolszczak-Biedrzycka B, Dorf J, Milewska A, Łukaszyk M, Naumnik W, Kosidło JW, et al. . Assessing the severity of COVID-19 symptoms based on the MEWS and predicting the risk of mortality. J Inflammation Res. (2023) 16:2173–88. doi: 10.2147/JIR.S406658</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S406658</ArticleId><ArticleId IdType="pmc">PMC10216858</ArticleId><ArticleId IdType="pubmed">37250104</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, et al. . Profiling serum cytokines in covid-19 patients reveals Il-6 and Il-10 are disease severity predictors. Emerg Microbes Infect. (2020) 9:1123–30. doi: 10.1080/22221751.2020.1770129</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1770129</ArticleId><ArticleId IdType="pmc">PMC7473317</ArticleId><ArticleId IdType="pubmed">32475230</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarique M, Suhail M, Naz H, Muhammad N, Tabrez S, Zughaibi TA, et al. . Where do T cell subsets stand in SARS-CoV-2 infection: an update? Front Cell Infect Microbiol. (2022) 12:964265. doi: 10.3389/fcimb.2022.964265</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.964265</ArticleId><ArticleId IdType="pmc">PMC9399648</ArticleId><ArticleId IdType="pubmed">36034704</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Fu B, Zheng X, Wang D, Zhao C, Qi Y, et al. . Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Natl Sci Rev. (2020) 7:998–1002. doi: 10.1093/nsr/nwaa041</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nsr/nwaa041</ArticleId><ArticleId IdType="pmc">PMC7108005</ArticleId><ArticleId IdType="pubmed">34676125</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkman SA, Tapson VF. Covid-19 and its implications for thrombosis and anticoagulation. Semin Respir Crit Care Med. (2021) 42:316–26. doi: 10.1055/s-0041-1722992</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0041-1722992</ArticleId><ArticleId IdType="pubmed">33548929</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge YL, Liu CH, Wang N, Xu J, Zhu XY, Su CS, et al. . Elevated plasma D-dimer levels in adult community-Acquired pneumonia patients is associated with an increased inflammatory reactions and lower survival. Clin Lab. (2019) 65. doi: 10.7754/Clin.Lab.2018.180720</Citation><ArticleIdList><ArticleId IdType="doi">10.7754/Clin.Lab.2018.180720</ArticleId><ArticleId IdType="pubmed">30775898</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalves FAR, Besen BAMP, de Lima CA, Corá AP, Pereira AJR, Perazzio SF, et al. . Use and misuse of biomarkers and the role of D-dimer and C-reactive protein in the management of COVID-19: A post-hoc analysis of a prospective cohort study. Clinics. (2021) 76:e3547. doi: 10.6061/clinics/2021/e3547</Citation><ArticleIdList><ArticleId IdType="doi">10.6061/clinics/2021/e3547</ArticleId><ArticleId IdType="pmc">PMC8612302</ArticleId><ArticleId IdType="pubmed">34909913</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>